v3.26.1
Leases
6 Months Ended
Jun. 30, 2026
Leases  
Leases
4. Leases

 

On January 1, 2025, the Company assumed an office lease from Duraviva Pharma Inc. (“Duraviva”), a New York corporation under common control, through a lease assignment agreement. The lease term extends through August 31, 2026. The Company classified the lease as an operating lease. Upon adoption of ASC 842, the Company recognized right-of-use asset and corresponding lease liability for its operating lease.

 

During the fourth quarter of 2025, the Company entered into lease agreements for three motor vehicles with non-cancelable lease terms ranging from 36 to 51 months.

 

The following summarizes information about the Company’s leases as of June 30, 2026 and December 31, 2025.

 

 Schedule of Lease

   2026   2025 
   For the Three Months Ended
June 30,
 
   2026   2025 
   (Unaudited)   (Unaudited) 
Amount recognized in the income statements          
           
Operating lease expense  $40,494   $17,404 

 

   2026   2025 
   For the Six Months Ended
June 30,
 
   2026   2025 
   (Unaudited)   (Unaudited) 
Amount recognized in the income statements          
           
Operating lease expense  $79,938   $34,807 

 

   As of
June 30, 2026
   As of
December 31, 2025
 
   (Unaudited)     
Amount recognized in the balance sheets          
           
Right-of-use assets  $280,939   $352,616 
Operating lease liabilities   276,359    346,699 
           
Cash paid for amounts included in the measurement of lease liabilities          
           
Operating lease expense  $80,199   $93,957 
           
Lease commitment          
           
2026  $99,803   $136,921 
2027   89,964    89,964 
2028   77,172    86,766 
2029   25,690    61,078 
Total future minimum lease payments   292,629    374,729 
less imputed interest   (16,270)   (28,030)
Present value of lease liabilities  $276,359   $346,699 
           
Supplemental information          
           
Weighted average discount rate   5.47%   5.47%
           
Weight average remaining lease term   41 months     47 months